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Abstract
Background: The purpose of this study was to examine racial and socio-economic differences in the receipt of
laparoscopic or open surgery among patients with colorectal cancer, and to determine if racial and socio-economic
differences exist in post-surgical complications, in-hospital mortality and hospital length of stay among patients
who received surgery.
Methods: We conducted a cross-sectional analysis of hospitalized patients with a primary diagnosis of colorectal
cancer between 2007 and 2011 using data from Nationwide Inpatient Sample. ICD-9 codes were used to capture
primary diagnosis, surgical procedures, and health outcomes during hospitalization. We used logistic regression
analysis to determine racial and socio-economic predictors of surgery type, post-surgical complications and
mortality, and linear regression analysis to assess hospital length of stay.
Results: A total of 122,631 patients were admitted with a primary diagnosis of malignant colorectal cancer
between 2007 and 2011. Of these, 17,327 (14.13 %) had laparoscopic surgery, 70,328 (57.35 %) received open
surgery, while 34976 (28.52 %) did not receive any surgery. Black (36 %) and Hispanic (34 %) patients were more
likely to receive no surgery compared with Whites (27 %) patients. However, among patients that received any
surgery, there were no racial differences in which surgery was received (laparoscopic versus open, p = 0.2122),
although socio-economic differences remained, with patients from lower residential income areas significantly less
likely to receive laparoscopic surgery compared with patients from higher residential income areas (OR: 0.74, 95 %
CI: 0.70-0.78). Among patients who received any surgery, Black patients (OR = 1.07, 95 % CI: 1.01-1.13), and patients
with Medicare (OR = 1.16, 95 % CI: 1.11-1.22) and Medicaid (OR = 1.15, 95 % CI: 1.07-1.25) insurance experienced
significantly higher post-surgical complications, in-hospital mortality (Black OR = 1.18, 95 % CI: 1.00-1.39), and longer
hospital stay (Black β = 1.33, 95 % CI: 1.16-1.50) compared with White patients or patients with private insurance.
Conclusion: Racial and socio-economic differences were observed in the receipt of surgery and surgical outcomes
among hospitalized patients with malignant colorectal cancer in the US.
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Background
Race/ethnic disparities in healthcare and outcomes
among the US colorectal cancer population is well docu-
mented, with Blacks experiencing higher incidence and
mortality compared with other race/ethnic groups [1–3].
Furthermore, since 1960, colorectal cancer mortality has
declined by 39 % among whites, but increased by 28 %
among blacks [2]. The increased mortality in blacks with
colorectal cancer can be attributed to differences in so-
cioeconomic status (SES) [4–6], tumor biology and stage
at diagnosis [7–9], comorbidities [4] treatment [5, 6, 10],
post-treatment surveillance [11, 12], physician character-
istics [13, 14], and hospital factors [15]. However, despite
adjustment for these factors in many studies, Black-
White differences in colorectal cancer survival have per-
sisted, worsened and are not fully understood [16–18].
Another predictor of the Black-White differences in
survival that has received less attention is the access to
and/or utilization of high-quality colorectal cancer treat-
ments. The gap between whites and blacks in colon
cancer surgery and chemotherapy has lessened over the
years, however, racial differences are still apparent
[6, 10]. Compared to whites, black patients were less
likely to undergo surgery for colorectal cancer [19–23]
and chemotherapy [19–26], and although advances in ad-
juvant therapy have improved survival in stage III and IV
disease [27], surgical resection remains the standard of
care for treating and staging non-metastatic colon cancer.
A major innovation in surgical techniques was the devel-
opment of laparoscopic colectomy for colon cancer, which
is considered a superior alternative to conventional open
colectomy based on findings from randomized trials and
meta-analyses [28–31]. These studies have consistently
concluded that laparoscopic colectomy is safe, feasible,
and associated with many short-term benefits compared
with open colectomy. In addition, laparoscopic surgery
has been associated with reduction of postoperative pain,
length of stay, and early mobilization compared with an
open colectomy [29, 32–35].
However while disparities in surgical treatment of
colorectal cancer between blacks and whites has been
well documented, it is unclear whether those disparities
extend to application of new surgical technologies. Sev-
eral studies that have examined data from the large Na-
tionwide Inpatient Sample (NIS) database have shown
inconsistent results regarding the impact of race on
colorectal surgical treatment; some studies indicated that
Whites were more likely to receive laparoscopic surgery
[36], while other studies found that race was not a pre-
dictor [30–32]. Many of these previous studies have been
using earlier NIS databases (1998–2004), which may be af-
fected by the accuracy of coding for laparoscopic proce-
dures. Furthermore, it remains unclear if the Black-White
differences in surgical outcomes (including mortality,
post-surgical complications and hospital length of stay)
persist after accounting for the type of surgery received.
The aim of this analysis is to examine differences in
receipt of colorectal cancer surgery (open and laparo-
scopic) and hospitalization outcomes among black and
white patients hospitalized with a primary diagnosis of
colorectal cancer. By utilizing data from the large NIS
database and focusing on inpatients that theoretically
have successfully accessed the healthcare system, we
simultaneously control for differences in access to care
as well as other potential confounders including demo-
graphic factors, tumor characteristics, and comorbidities.
Determining the influence of race/ethnicity on the type
of surgical colorectal cancer treatment received, and as-
sociated cancer outcomes may help to further shed light
on the persistent disparities in colorectal cancer out-
comes between black and white patients in the U.S,
highlighting areas where targeted efforts may be focused
to improve survival for all colorectal cancer patients.
Methods
This is a cross-sectional analysis of hospitalized patients
between 2007 and 2011 with a primary diagnosis of
colorectal cancer. The inpatient data were obtained from
the Health Cost and Utilization Project Nationwide In-
patient Sample (HCUP-NIS). The HCUP-NIS is a large
all-payer inpatient care database covering over 1000 hos-
pitals in the U.S., with data on over seven million hospi-
tals stays per year [37]. The HCUP-NIS database
contains clinical and nonclinical data elements for each
hospital stay, including clinical variables for all diagnoses
and procedures occurring during admission. Non-
clinical variables are also included, such as median
household income in the patient’s zip code, rural/urban
residence, and expected payment source. More informa-
tion on HCUP-NIS can be obtained at: https://
www.hcup-us.ahrq.gov/nisoverview.jsp.
Clinical variables
Primary diagnosis of malignant colorectal cancer was cap-
tured using International Classification of Disease, Ninth
edition (ICD-9) codes (153.X, 154.0-154.3, 154.8). We cre-
ated a proxy colorectal cancer stage variable, classifying
malignant colorectal cancer patients into metastatic and
non-metastatic (ICD-9 codes: 196.X, 197.X, 198.X) since
the HCUP dataset does not include cancer stage variables.
For the major comorbid conditions, we created a modified
Deyo comorbidity index using ICD-9 codes. The condi-
tions included cerebrovascular disease, congestive heart
failure, chronic pulmonary disease, diabetes mellitus
with or without chronic complications, dementia, myo-
cardial infarctions, peripheral vascular disease, rheum-
atic disease, peptic ulcer disease, mild liver disease,
hemiplegia or paraplegia, renal disease, moderate or
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severe liver disease, and HIV/AIDS. The presence of
each condition within each patient was identified. A sin-
gle comorbidity score was created as the sum of the
number of conditions per patient, and this approach of
using the Charleston index as modified by Deyo has
been previously examined in the NIS database [38–40].
Individual variables
Other covariates used in the analysis include race/ethnicity,
categorized into White, Black, Hispanic, and Other (Other
included Asians, Pacific Islanders, Native Americans and
Other races combined due to low sample sizes), residential
income, insurance type and residential region. Residential
income was divided into quartiles ranging from the lowest
income to the highest income based on median household
income at the zip-code level. Residential region was catego-
rized into large metropolitan areas (metropolitan areas with
1 million residents or more), small metropolitan areas
(metropolitan areas with less than 1 million residents), mi-
cropolitan areas (Non-metropolitan areas adjacent to
metropolitan areas) and non-metropolitan or micropolitan
areas (noncore areas with or without its own town)
using the 2003 version of the Urban Influence Codes
[41]. Insurance status was classified into Medicaid,
Medicare, private (includes Blue Cross, commercial car-
riers, private HMOs and PPOs, and self-insured) and
others (includes Worker’s Compensation, Title V, and
other government programs) [37].
Outcome measures
There were two main objectives of this study. First was
to examine racial and socio-economic differences in the
receipt of laparoscopic or open surgery procedures
among patients with malignant colorectal cancer; and
second, to determine racial and socio-economic differ-
ences in post-surgical complications, in-hospital mortal-
ity and hospital length of stay among patients who
received colorectal laparoscopic or open surgery. Our
analyses were based on two datasets, the full dataset
with all colorectal cancer patients, and the reduced data-
set with only patients who received laparoscopic or open
surgery. ICD-9 procedure codes were used to identify
laparoscopic (ICD-9 codes: 17.33-17.36, 17.39, 45.81,
48.42, 48.51) and open (ICD-9 codes: 45.7X, 45.80,
45.82, 48.43, 48.52, 48.62, 48.63) surgery. The length of
hospital stay was calculated by subtracting the admission
date from the discharge date with same-day stays coded
as 0. In-hospital mortality was identified as deaths oc-
curring during hospitalization. ICD-9 diagnosis codes
were used to identify the presence of post-surgical com-
plications, which include mechanical wounds, infections,
urinary, pulmonary, gastrointestinal, cardiovascular and
intra-operative complications. Since the dataset only in-
cludes information collected during hospital admissions,
our analysis excluded complications and mortality oc-
curring after hospital discharge.
Statistical analysis
We examined the race/ethnicity and socio-economic dif-
ferences in study characteristics using Chi-square tests for
categorical variables and ANOVA for continuous variables
(age, length of stay, number of comorbidities). Multi-
nomial logistic regression analysis was conducted to deter-
mine the association between laparoscopic surgery and
open surgery versus no surgery and logistic regression
analysis was conducted to determine the association
between laparoscopic surgery versus open surgery
among those who received any surgery, and adjusted
for race/ethnicity, age, sex, diagnosis year, stage, residential
income, insurance type, and residential region.). To exam-
ine the associations between race/ethnicity and residential
income with post-operative complications, logistic regres-
sion was restricted to patients who received surgery
adjusting for race/ethnicity, age, sex, diagnosis year, stage,
residential income, insurance type, and residential region.
Linear regression models were computed to examine the
associations with hospital length of stay using the reduced
dataset. All statistical analyses were conducted in SAS 9.4.
Results
A total of 122,631 hospitalized patients were identified
with a primary diagnosis of malignant colorectal cancer
between 2007 and 2011. Among them, 17,327 (14.13 %)
had laparoscopic surgery, 70,328 (57.35 %) received open
surgery, while 34976 (28.52 %) did not receive any sur-
gery. Table 1 shows the socio-demographic and clinical
distributions of study participants by race. The majority
of patients were White (74 %), while (11.8 %) were
Black, 7.3 % were Hispanic and 6.4 % were of Other
race. White patients were older at the time of admission
(mean age: 68.8) compared with Blacks (mean age 63.8),
Hispanics (mean age 63.5) and Other racial groups
(mean age 65.4), and the majority of Black patients
(50.4 %) lived in the lowest residential income areas
compared with 22.0 % of White, 36.1 % of Hispanic and
19.7 % of Other races. There were also racial differences
in the clinical variables. White patients were less likely
to present with metastatic disease (34.8 %) compared
with Blacks (40.8 %), Hispanics (35.5 %) and other racial
groups (36.8 %). White patients were also more likely to
receive laparoscopic or open surgery compared with
other racial groups; 26.5 % of Whites received no sur-
gery compared with 36.4 % of Blacks, 33.9 % of His-
panics and 31.3 % of Other racial groups. However,
White patients were more likely to have two or more
post-surgical complications (8.5 %) compared with 7.9 %
of Blacks, 6.7 % of Hispanics and 6.1 % of Other racial
groups.
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Table 2 presents the results of multivariable logistic re-
gression models examining factors associated with the
receipt of laparoscopic or open surgery against no sur-
gery, adjusted for age, sex, diagnosis year, race, income,
stage, insurance, residential region and comorbidities.
There were significant differences in receipt of surgery
by age, sex, race/ethnicity, income, stage, insurance, re-
gion and comorbidities (p < .0001). Compared with
males, females were significantly (p < .0001) more likely
to receive both laparoscopic (OR = 1.19, 95 % CI: 1.14-
1.24) and open surgery (OR = 1.10, 95 % CI: 1.07-1.13),
and Black (laparoscopic OR = 0.74, 95 % CI: 0.69-0.79;
open OR = 0.75, 95 % CI: 0.72-0.79), Hispanic (laparo-
scopic OR = 0.88, 95 % CI: 0.82-0.95; open OR = 0.83,
95 % CI: 0.79-0.88) and Other racial group (laparoscopic
OR: 0.85, 95 % CI: 0.79-0.93; open OR = 0.90, 95 % CI:
0.86-0.96) patients were significantly less likely to receive
surgery compared with White patients. In addition,
Table 1 Distribution of baseline characteristics by race among colorectal cancer patients, Nationwide Inpatient Sample, 2007-2011
Race
Study Characteristics










Female 45203 (49.5) 7542 (52.0) 4074 (45.6) 3816 (48.6)
Male 46136 (50.5) 6958 (48.0) 4856 (54.4) 4039 (51.4)
Age at admission (years) 68.8 (13.8) 63.8 (13.6) 63.5 (14.6) 65.4 (14.3)
Length of Stay (days) 8.2 (7.2) 9.4 (9.2) 8.5 (7.8) 8.2 (8.1)
Number of Comorbidities 0.4 (0.7) 0.4 (0.7) 0.3 (0.7) 0.3 (0.6)
Residential income
First Quartile-Lowest 19691 (22.0) 7090 (50.4) 3121 (36.1) 1482 (19.7)
Second Quartile 19691 (22.0) 3026 (21.5) 1975 (22.8) 1637 (21.8)
Third Quartile 22656 (25.3) 2264 (16.1) 2148 (24.8) 1919 (25.5)
Fourth Quartile-Highest 23834 (26.6) 1680 (12.0) 1413 (16.3) 2484 (33.0)
Insurance Type
Medicare 54489 (59.7) 6779 (46.8) 3865 (43.3) 3511 (44.7)
Medicaid 3663 (4.0) 1917 (13.2) 1430 (16.0) 1028 (13.1)
Private 28720 (31.4) 4351 (30.0) 2593 (29.0) 2658 (33.8)
Other 4472 (4.9) 1453 (10.0) 1042 (11.7) 660 (8.4)
Residential Region
Large Metro 43411 (54.1) 9507 (70.3) 6514 (77.1) 5537 (75.4)
Small Metro 25867 (32.2) 2927 (21.6) 1521 (18.0) 1320 (18.0)
Micropolitan 11027 (13.7) 1099 (8.1) 418 (5.0) 490 (6.7)
Stage at presentation
Non-Metastatic 59539 (65.2) 8586 (59.2) 5757 (64.5) 4967 (63.2)
Metastatic 31805 (34.8) 5914 (40.8) 3173 (35.5) 2890 (36.8)
Surgery
Laparoscopic 13285 (14.5) 1766 (12.2) 1231 (13.8) 1045 (13.3)
Open 53844 (59.0) 7459 (51.4) 4669 (52.3) 4356 (55.4)
No surgery 24215 (26.5) 5275 (36.4) 3030 (33.9) 2456 (31.3)
Complications
0 61525 (67.4) 10096 (69.6) 6630 (74.2) 5918 (75.3)
1 21678 (23.7) 3254 (22.4) 1700 (19.0) 1459 (18.6)
> =2 8141 (8.9) 1150 (7.9) 600 (6.7) 480 (6.1)
Died during Hospitalization
No 87932 (96.3) 13843 (95.5) 8623 (96.7) 7563 (96.3)
Yes 3342 (3.7) 649 (4.5) 299 (3.4) 291 (3.7)
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compared with patients residing in the highest residen-
tial income areas, those in lower residential income
areas were significantly less likely to receive laparoscopic
(OR = 0.64, 95 % CI: 0.60-0.68) and open (OR = 0.86,
95 % CI: 0.82-0.90) surgery. However, among patients
that received any surgery, there were no significant racial
differences in which surgery was received (laparoscopic
versus open, p = 0.2122), although socio-economic dif-
ferences remained, with patients from lower residential
income areas significantly less likely to receive laparo-
scopic surgery compared with patients from higher resi-
dential income areas (OR: 0.74, 95 % CI: 070–0.78).
Table 3 presents the results of multivariable analysis of
post-surgical outcomes among colorectal cancer patients
who received either laparoscopic or open surgery. There
were significant differences in the odds of post-surgical
complications by race (p = 0.0021), socio-economic (p =
0.0472) and insure type (p < .0001). Post-surgical compli-
cations were significantly higher among Black patients
(OR = 1.07, 95 % CI: 1.01-1.13), but lower among Hispanic
patients (OR = 0.93, 95 % CI: 0.87-0.99) compared with
White patients. Patients with Medicare (OR = 1.16, 95 %
CI: 1.11-1.22) and Medicaid (OR = 1.15, 95 % CI: 1.07-
1.25) insurance types also experienced more post-surgical
Table 2 Multivariable logistic regression models of Laparoscopic Surgery and Open Surgery, Nationwide Inpatient Sample, 2007-2011
Laparoscopica Open Surgerya Laparoscopic vs.
Open Surgeryb
N OR (95 % CI) N OR (95 % CI) P-value OR (95 % CI) P-value
Age 19221 0.99(0.93, 0.99) 84429 0.99 (0.99, 0.98) <.0001 1.00 (0.99, 1.00) 0.7739
Sex <.0001 <.0001
Male 9280 Ref 42324 Ref Ref
Female 9878 1.19 (1.14, 1.24) 41983 1.10 (1.07, 1.13) 1.09 (1.05, 1.13)
Race/Ethnicity <.0001 0.2122
White 13285 Ref 53054 Ref Ref
Black 1766 0.74 (0.69, 0.79) 7325 0.75 (0.72, 0.79) 0.97 (0.91, 1.04)
Hispanic 1231 0.88 (0.82, 0.95) 4606 0.83 (0.79, 0.88) 1.05 (0.98, 1.13)
Other 1045 0.85 (0.79, 0.93) 4311 0.90 (0.86, 0.96) 0.95 (0.88, 1.03)
Residential Income <.0001 <.0001
Q4-Highest 5285 Ref 19219 Ref Ref
Q3 4985 0.86 (0.82, 0.91) 20253 0.97 (0.93, 1.01) 0.89 (0.85, 0.94)
Q2 4619 0.78 (0.74, 0.83) 21873 0.90 (0.86, 0.94) 0.86 (0.82, 0.91)
Q1-Lowest 3953 0.64 (0.60, 0.68) 21347 0.86 (0.82, 0.90) 0.74 (0.70, 0.78)
Stage <.0001 <.0001
Non-Metastatic 14865 Ref 56421 Ref Ref
Metastatic 4356 0.37 (0.35, 0.38) 29246 0.66 (0.64, 0.68) 0.57 (0.54, 0.59)
Insurance Type <.0001 <.0001
Private 6884 Ref 27472 Ref Ref
Medicare 10863 0.94 (0.89, 0.99) 48239 0.99 (0.96, 1.04) 0.94 (0.89, 0.99)
Medicaid 693 0.28 (0.25, 0.31) 4283 0.48 (0.46, 0.51) 0.57 (0.51, 0.63)
Other 781 0.34 (0.31, 0.38) 4435 0.56 (0.53, 0.59) 0.63 (0.57, 0.69)
Residential Region <.0001 <.0001
Large metro 10950 Ref 41199 Ref Ref
Small metro 4974 0.99 (0.94, 1.04) 23398 1.18 (1.14, 1.22) 0.83 (0.79, 0.87)
Micropolitan 1699 0.82 (0.76, 0.88) 10561 1.25 (1.20, 1.31) 0.64 (0.60, 0.69)
Comorbidities <.0001 <.0001
0 13721 Ref 58363 Ref Ref
1 4115 0.79 (0.75, 0.83) 19119 0.89 (0.86, 0.92) 0.89 (0.84, 0.93)
≥ 2 1385 0.64 (0.59, 0.69) 6947 0.80 (0.76, 0.85) 0.81 (0.75, 0.87)
Adjusted for age, sex, diagnosis year, race, income, stage, insurance, residential region and comorbidities
aMultinomial regression model for laparoscopic surgery and open surgery versus no surgery
bMultivariable logistic regression model comparing laparoscopic surgery versus open surgery among CRC patients who received surgery
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complications compared with those with private in-
surance. There were also racial differences in mortality
outcomes, with Black patients more likely to experience
in-hospital mortality (OR = 1.18, 95 % CI: 1.00-1.39) com-
pared with Whites. In addition, patients residing in the
lowest residential income areas (OR: 1.30, 95 % CI: 1.11-
1.51) and patients without private insurance (OR: 1.95,
95 % CI: 1.49-2.56) were more likely to experience in-
hospital mortality.
Furthermore, Black patients (β = 1.33, 95 % CI: 1.16-
1.50) experienced significantly longer hospital stay com-
pared with Whites, as did patients of lower residential
income areas (β = 0.84, 95 % CI: 0.68-1.00). Patients with
Medicaid (β = 2.91, 95 % CI: 2.66-3.16) and other
insurance types (β = 1.72, 95 % CI: 1.47-1.96) had
approximately up to 3.5 days longer hospital stays,
respectively, compared with patients with private insur-
ance. Conversely, patients in small metropolitan (β = −0.36,
95 % CI: −0.48 to −0.24) and micropolitan areas (β = −0.71,
95 % CI; −0.88 to −0.54) had significantly shorter hos-
pital stays compared with patients in large metropolitan
areas (Table 4).
Discussion
In this study we examined race/ethnicity and SES dispar-
ities in colorectal cancer surgery and post-surgical
outcomes among hospitalized patients in the large
Nationwide Inpatient Sample dataset, representative of
Table 3 Multivariable logistic regression analysis of outcomes after colorectal cancer surgery, Nationwide Inpatient Sample, 2007-2011
Study Characteristics N (%) Post-Surgical Complicationsa
OR (95 % CI)
P-value In-Hospital Mortalitya
OR (95 % CI)
P-value
Age 104834 1.01 (1.01, 1.01) <.0001 1.05 (1.05, 1.06) <.0001
Sex <.0001 <.0001
Male 52193 (49.8) Ref Ref
Female 52510 (50.2) 0.77 (0.73, 0.81) 0.72 (0.65, 0.79)
Race/Ethnicity 0.0021 0.0364
White 66339 (76.6) Ref Ref
Black 9091 (10.5) 1.07 (1.01, 1.13) 1.18 (1.00, 1.39)
Hispanic 5837 (6.7) 0.93 (0.87, 0.99) 1.01 (0.82, 1.24)
Other 5356 (6.2) 0.96 (0.90, 1.02) 0.79 (0.63, 1.01)
Residential Income 0.0472 0.0080
Q4-Highest 24504 (24.1) Ref Ref
Q3 25238 (24.9) 1.05 (1.01, 1.10) 1.19 (1.03, 1.36)
Q2 26492 (26.1) 1.01 (0.96, 1.06) 1.20 (1.04, 1.39)
Q1-Lowest 25300 (24.9) 0.99 (0.95, 1.04) 1.30 (1.11, 1.51)
Stage <.0001 <.0001
Non-Metastatic 5397 (13.5) Ref Ref
Metastatic 24142 (60.3) 1.17 (1.13, 1. 21) 1.80 (1.63, 1.99)
Insurance Type <.0001 <.0001
Private 34356 (33.6) Ref Ref
Medicare 59102 (57.0) 1.16 (1.11, 1.22) 1.23 (1.05, 1.45)
Medicaid 4976 (4.8) 1.15 (1.07, 1.25) 1.66 (1. 23, 2.22)
Other 5216 (5.0) 1.03 (0.95, 1.12) 1.95 (1.49, 2.56)
Residential Region 0.0116 0.6859
Large metro 52149 (56.2) Ref Ref
Small metro 28372 (30.6) 0.95 (0.91, 0.99) 0.96 (0.86, 1.08)
Micropolitan 12260 (13.2) 1.01 (0.95, 1.06) 0.95 (0.80, 1.08)
Comorbidities <.0001 <.0001
0 72084 (69.6) Ref Ref
1 23234 (22.4) 1.19 (1.14, 1.23) 1.86 (1.67, 2.08)
≥ 2 8332 (8.0) 1.19 (1.13, 1.26) 3.11 (2.73, 3.54)
aAdjusted for age, sex, diagnosis year, race, income, stage, insurance, residential region and comorbidities
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hospitalized patients in the U.S. Our analysis of hospital-
ized patients, who have successfully accessed healthcare
revealed that there remained significant racial and SES
disparities in the receipt and type of colorectal cancer
surgery as well as subsequent clinical outcomes. Black
patients were less likely to receive any type of surgery
compared with other racial groups, however, among pa-
tients that received surgery, there were no racial differ-
ences but significant socio-economic differences in the
type of surgery received. Patients of lower residential in-
come areas, those with Medicaid or Other insurance
types, and patients residing outside of large metropolitan
areas were less likely to receive laparoscopic surgery.
These differences may account for the racial and socio-
economic differences observed in post-surgical compli-
cations, in-hospital mortality and hospital length of stay.
Starting in the late 1980s and throughout the 1990s,
reports appeared in the literature describing the inequal-
ities in dissemination of new treatments for colorectal
cancer and other cancer experienced by minority popu-
lations, especially Blacks, in the United States [19–26],
fostering interest as to why these racial discrepancies
exist. Multiple factors are believed to contribute to dif-
ferences in surgical treatment among colorectal cancer
patients, including disease characteristics, comorbidities,
patients’ demographic factors, factors related to the
health system, and surgeon experience [42–44]. Similar
to other studies within the NIS patient population data-
bases [30–32, 36], our findings suggest that non-White
patients remained less likely to receive any surgery com-
pared with White patients, although among those who
did receive surgery, there were no racial differences in
the type of surgery received. One possible explanation is
that laparoscopic surgery is often performed on younger
patients with less complicated disease, possibly reflecting
the individual surgeon’s comfort level with the procedure
[45]. We observed an independent influence of socio-
economic status on type of surgery received, suggesting
that patients with higher socio-economic status are the
most likely recipients laparoscopic surgery. It remains an
open question whether these patients also happen to be
the most ideal candidate for this surgery type based on
their disease status and other comorbidities; we did not
observe an independent association between number of
comorbidities and type of surgery received after adjust-
ing for race and residential income.
Black patients and patients of lower socio-economic
status experienced worse hospitalization outcomes, with
more post-surgical complications, in-hospital mortality
and longer hospital stay compared with Whites and pa-
tients of other race. Furthermore, worse outcomes were
observed among residents of lower residential income
areas, and patients with non-private insurance. These
findings provide additional evidence of the dispropor-
tionate burden of colorectal cancer morbidity and mor-
tality among Black and low-SES populations [46–51],
which is not necessarily explained by differential access
to healthcare since hospitalized patients have theoretic-
ally already accessed the health system. Our findings also
corroborate studies in the literature suggesting that hav-
ing health insurance does not uniformly increase access
or use of health care services [52, 53]. We observed an
independent influence of insurance type on outcomes
Table 4 Multivariable linear regression analysis of in-hospital












Black 1.33 (1.16, 1.50)
Hispanic 0.18 (−0.02, 0.39)
Other 0.09 (−0.12, 0.30)
Residential Income <.0001
Q4-Highest Ref
Q3 0.33 (0.18, 0.47)
Q2 0.37 (0.22, 0.52)
Q1-Lowest 0.84 (0.68, 1.00)
Stage <.0001
Non-Metastatic Ref
Metastatic 1.76 (1.65, 1.87)
Insurance Type <.0001
Private Ref
Medicare 0.66 (0.51, 0.81)
Medicaid 2.91 (2.66, 3.16)
Other 1.72 (1.47, 1.96)
Residential Region <.0001
Large metro Ref




1 1.52 (1.40, 1.65)
≥ 2 3.01 (2.82, 3.21)
aLength of hospital stay was calculated by subtracting the admission date
from the discharge date with same-day stays coded as 0
bAdjusted for age, sex, diagnosis year, race, income, stage, insurance,
residential region and comorbidities
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even after adjusting for race and residential income;
patients without private insurance, usually obtained
through employment, were less likely to receive surgery,
and those that did receive any surgery were less likely to
receive laparoscopic surgery. Patients on Medicare and
Medicaid may experience difficulties in finding health-
care providers, since reimbursement rates for these in-
surance types are usually significantly lower than those
offered by private insurance [3, 54]. Thus, patients with
non-private insurance may present at advanced disease
stages, experience delayed treatment, may be offered less
expensive treatment options, and/or may have other
health-related conditions making them less suitable can-
didates for surgery [55–57]. Other factors such as cul-
tural beliefs, patient preferences and social support may
also exert significant influences on treatment choice,
type, and outcome. More subjective factors such as qual-
ity of patient-physician communication, discrimination,
and capacity to navigate health system bureaucracies
may also play a role in treatment outcome, even
among hospitalized patients already within the health-
care system [58].
Although our study benefited from large sample sizes
and objective measures of diagnoses and procedures,
there are some limitations associated with this observa-
tional study using administrative data. The NIS database
is discharge specific and does not allow long-term
follow-up at the patient level. ICD-9-CM diagnostic and
procedure codes were used to identify procedures exam-
ined in the study, and the possibility of coding errors
and missing procedure or diagnosis codes exists. Fur-
thermore, we could not discern whether some of the ra-
cial differences in treatment were due to personal
patient preferences, thus future studies are needed to
fully explore the extent to which patient preference in-
fluences type of treatment and outcomes. We were un-
able to assess non-surgical forms of treatment such as
chemotherapy and radiotherapy, as detailed information
regarding these data items are not readily available in
HCUP. Finally, in order to be effective at capturing so-
cioeconomic gradients in cancer outcomes, several stud-
ies used a measure of census tract or census block with
a priori cut-points [59–61]. However, due to patient
privacy concerns, residential level SES was only provided
at the zip-code level, therefore this could likely lead to
an underestimation of our SES estimates.
Conclusion
There were racial and socio-economic differences ob-
served in the receipt of surgery, and surgical outcomes
among hospitalized patients with malignant colorectal
cancer. Although laparoscopic surgery for colorectal
cancer is now widely accepted as the treatment of choice
for colorectal cancer, further studies are needed to better
understand factors associated with treatment type that
may be racially patterned, including individual and phys-
ician level factors that may influence the treatment deci-
sions. In addition, future studies are needed to identify
reasons underlying differences in the receipt of laparo-
scopic surgery by insurance coverage and residential re-
gion. Determining whether these differences are due to
limited availability of trained personnel and/or surgical
equipment, high out-of-pocket costs, or other reasons
may help inform policies designed to eliminate such bar-
riers, ultimately improving hospitalization outcomes for
all patients with colorectal cancer.
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